Bearish flow noted in GSK (GSK) Pharma with 2,296 puts trading, or 1.2x expected. Most active are May-25 30 puts and Dec-24 38 calls, with total volume in those strikes near 2,500 contracts.

Clinical study reports for the FURI, CARES and NATURE trials in refractory or resistant invasive fungal infections were delivered to GSK, ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

It stands out in a region where Amish farms and hills covered with second-growth red-oak woods, parks, and hiking trails ...

Explore first person business intelligence from top minds curated for a global executive audience The 16th edition of the ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

Walmsley said Mackay has "played a very significant role to help deliver the reshaping of GSK and to improve our operating and financial performance," and welcomed the new CFO, highlighting Brown ...

An icon in the shape of a lightning bolt ... with drops in December and April. The new AI software is only available on iPhone 15 Pro or later. Its upcoming launch is expected to be on December ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

Would Donald J. Trump come to the aid of Mayor Eric Adams of New York, an embattled Democrat indicted on federal corruption charges? By Jan Ransom While other big state Democrats are reviving ...